NDC 0069-0469

CHANTIX

Varenicline Tartrate

CHANTIX is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Varenicline Tartrate.

Product ID0069-0469_1ec8e989-320f-438d-882c-201b0fe6b23f
NDC0069-0469
Product TypeHuman Prescription Drug
Proprietary NameCHANTIX
Generic NameVarenicline Tartrate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2006-05-10
Marketing CategoryNDA / NDA
Application NumberNDA021928
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NameVARENICLINE TARTRATE
Active Ingredient Strength1 mg/1
Pharm ClassesPartial Cholinergic Nicotinic Agonist [EPC],Partial Cholinergic Nicotinic Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0069-0469-03

1 BLISTER PACK in 1 CARTON (0069-0469-03) > 56 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Start Date2006-05-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0069-0469-11 [00069046911]

CHANTIX TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-06-13
Marketing End Date2019-05-15

NDC 0069-0469-03 [00069046903]

CHANTIX TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-05-10

NDC 0069-0469-56 [00069046956]

CHANTIX TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-05-10

NDC 0069-0469-97 [00069046997]

CHANTIX TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-05-10
Marketing End Date2015-02-03

NDC 0069-0469-12 [00069046912]

CHANTIX TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021928
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-05-10
Marketing End Date2018-02-28

Drug Details

Active Ingredients

IngredientStrength
VARENICLINE TARTRATE1 mg/1

OpenFDA Data

SPL SET ID:f0ff4f27-5185-4881-a749-c6b7a0ca5696
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 636671
  • 636676
  • 795737
  • 749289
  • 637188
  • 749788
  • 637190
  • 795735
    • UPC Code
  • 0300690469560

    • Pharmacological Class

    • Partial Cholinergic Nicotinic Agonist [EPC]
    • Partial Cholinergic Nicotinic Agonists [MoA]

    NDC Crossover Matching brand name "CHANTIX" or generic name "Varenicline Tartrate"

    NDCBrand NameGeneric Name
    0069-0468CHANTIXvarenicline tartrate
    0069-0469CHANTIXvarenicline tartrate
    0069-0471CHANTIXvarenicline tartrate
    21695-633Chantixvarenicline tartrate
    21695-945CHANTIXvarenicline tartrate
    21695-946Chantixvarenicline tartrate
    43353-899CHANTIXvarenicline tartrate
    50090-0995CHANTIXvarenicline tartrate
    50090-0998CHANTIXvarenicline tartrate
    50090-3528CHANTIXvarenicline tartrate
    50090-4481CHANTIXvarenicline tartrate
    50090-4482CHANTIXvarenicline tartrate
    63187-618CHANTIXvarenicline tartrate
    63539-473CHANTIXvarenicline tartrate
    68151-4953CHANTIXCHANTIX
    68151-4952CHANTIXCHANTIX
    69189-0492CHANTIXCHANTIX
    71205-381CHANTIXCHANTIX
    49884-155Vareniclinevarenicline tartrate
    49884-156Vareniclinevarenicline tartrate
    49884-944Vareniclinevarenicline tartrate
    60687-648Vareniclinevarenicline tartrate

    Trademark Results [CHANTIX]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CHANTIX
    CHANTIX
    88847451 not registered Live/Pending
    Pfizer Inc.
    2020-03-25
    CHANTIX
    CHANTIX
    88847449 not registered Live/Pending
    Pfizer Inc.
    2020-03-25
    CHANTIX
    CHANTIX
    78893080 3407173 Live/Registered
    Pfizer Inc.
    2006-05-25
    CHANTIX
    CHANTIX
    78875811 not registered Dead/Abandoned
    Pfizer Inc.
    2006-05-03
    CHANTIX
    CHANTIX
    78835879 3321317 Live/Registered
    Pfizer Inc.
    2006-03-13
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.